Cas:158752-98-8 dipyrrolidin-1-ylboranyl(dipyrrolidin-1-yl)borane manufacturer & supplier

We serve Chemical Name:dipyrrolidin-1-ylboranyl(dipyrrolidin-1-yl)borane CAS:158752-98-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

dipyrrolidin-1-ylboranyl(dipyrrolidin-1-yl)borane

Chemical Name:dipyrrolidin-1-ylboranyl(dipyrrolidin-1-yl)borane
CAS.NO:158752-98-8
Synonyms:Tetrakis(pyrrolidino)diborane;MFCD04974105;TETRAKIS(PYRROLIDIN-1-YL)DIBORANE;tetrapyrrolidinodiborane;[(N-pyrrolidine)2B]2;tetra(pyrrolidino)diborane(4)
Molecular Formula:C16H32B2N4
Molecular Weight:302.07400
HS Code:

Physical and Chemical Properties:
Melting point:78-82ºC(lit.)
Boiling point:395.9ºC at 760 mmHg
Density:1.05g/cm3
Index of Refraction:1.543
PSA:12.96000
Exact Mass:302.28100
LogP:1.17600

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3263 8/PG 3
Packing Group:


Contact us for information like Tetrakis(pyrrolidino)diborane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tetra(pyrrolidino)diborane(4) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,TETRAKIS(PYRROLIDIN-1-YL)DIBORANE Use and application,Tetrakis(pyrrolidino)diborane technical grade,usp/ep/jp grade.


Related News: During analysis of the clinical trial data, the researchers realized that about a third of the participants had low levels of abnormal tau protein, which makes them not very suitable for evaluating the effects of a treatment halting the progression of tau pathology. dipyrrolidin-1-ylboranyl(dipyrrolidin-1-yl)borane manufacturer For example, an active ingredient to relieve pain is included in a painkiller. dipyrrolidin-1-ylboranyl(dipyrrolidin-1-yl)borane supplier Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country. dipyrrolidin-1-ylboranyl(dipyrrolidin-1-yl)borane vendor During analysis of the clinical trial data, the researchers realized that about a third of the participants had low levels of abnormal tau protein, which makes them not very suitable for evaluating the effects of a treatment halting the progression of tau pathology. dipyrrolidin-1-ylboranyl(dipyrrolidin-1-yl)borane factory For example, an active ingredient to relieve pain is included in a painkiller.